Senzime AB (SEZI) - Total Liabilities
Based on the latest financial reports, Senzime AB (SEZI) has total liabilities worth Skr65.35 Million SEK (≈ $7.03 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore SEZI cash generation efficiency to assess how effectively this company generates cash.
Senzime AB - Total Liabilities Trend (2005–2025)
This chart illustrates how Senzime AB's total liabilities have evolved over time, based on quarterly financial data. Check SEZI asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Senzime AB Competitors by Total Liabilities
The table below lists competitors of Senzime AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Farmsco
KO:036580
|
Korea | ₩901.42 Billion |
|
Ispire Technology Inc. Common Stock
NASDAQ:ISPR
|
USA | $92.06 Million |
|
Cheng Fwa Industrial Ltd
TWO:5426
|
Taiwan | NT$962.31 Million |
|
Yew Lee Pacific Group Berhad
KLSE:0248
|
Malaysia | RM3.26 Million |
|
Highland Copper Company Inc.
V:HI
|
Canada | CA$13.38 Million |
|
Ibkimyoung Co. Ltd
KQ:339950
|
Korea | ₩53.78 Billion |
|
Progress-Werk Oberkirch AG
XETRA:PWO
|
Germany | €271.95 Million |
|
Space Shuttle Hi-Tech Co Ltd
TW:2440
|
Taiwan | NT$1.28 Billion |
Liability Composition Analysis (2005–2025)
This chart breaks down Senzime AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Senzime AB market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.78 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 2.19 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Senzime AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Senzime AB (2005–2025)
The table below shows the annual total liabilities of Senzime AB from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr65.35 Million ≈ $7.03 Million |
-16.94% |
| 2024-12-31 | Skr78.67 Million ≈ $8.47 Million |
+35.49% |
| 2023-12-31 | Skr58.06 Million ≈ $6.25 Million |
-4.46% |
| 2022-12-31 | Skr60.78 Million ≈ $6.54 Million |
+152.80% |
| 2021-12-31 | Skr24.04 Million ≈ $2.59 Million |
-12.72% |
| 2020-12-31 | Skr27.55 Million ≈ $2.96 Million |
+14.45% |
| 2019-12-31 | Skr24.07 Million ≈ $2.59 Million |
-19.10% |
| 2018-12-31 | Skr29.75 Million ≈ $3.20 Million |
+16.33% |
| 2017-12-31 | Skr25.57 Million ≈ $2.75 Million |
+4.63% |
| 2016-12-31 | Skr24.44 Million ≈ $2.63 Million |
+1126.44% |
| 2015-12-31 | Skr1.99 Million ≈ $214.46K |
-10.94% |
| 2014-12-31 | Skr2.24 Million ≈ $240.79K |
+91.47% |
| 2013-12-31 | Skr1.17 Million ≈ $125.76K |
-6.29% |
| 2012-12-31 | Skr1.25 Million ≈ $134.19K |
-67.12% |
| 2011-12-31 | Skr3.79 Million ≈ $408.17K |
-5.82% |
| 2010-12-31 | Skr4.03 Million ≈ $433.39K |
-11.76% |
| 2009-12-31 | Skr4.56 Million ≈ $491.13K |
-5.42% |
| 2008-12-31 | Skr4.83 Million ≈ $519.27K |
+11.44% |
| 2007-12-31 | Skr4.33 Million ≈ $465.98K |
+34.39% |
| 2006-12-31 | Skr3.22 Million ≈ $346.74K |
+7.22% |
| 2005-12-31 | Skr3.00 Million ≈ $323.39K |
-- |
About Senzime AB
Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. The company offers TetraGraph, a quantitative neuromuscular transmission monitor, which supports neuromuscular blockade management from induction to recovery; and ExSpiron, a non-invasive … Read more